2026.3.13
TCROSS Co., Ltd. announced that its CEO, Satoru Hashimoto, delivered a presentation at HIMSS 2026, one of the world's largest healthcare IT conferences held in Las Vegas. The presentation, titled "AI-Powered Pharma Marketing: Eliminating Waste, Maximizing Impact," introduced EarlyScripters, a new feature of our marketing analytics platform InsighTCROSS.
EarlyScripters is an AI-driven technology designed to identify physicians who are highly likely to prescribe newly launched drugs at an early stage (early adopters). The system further analyses the characteristics of these physicians and identifies similar doctors across the broader population. This technology was granted a patent in Japan in January 2026.
Previous studies have reported that identifying early prescribers is a key factor influencing the early and mid-term sales performance of new pharmaceutical products. However, traditional approaches have largely relied on the intuition and experience of sales representatives, often resulting in inconsistent outcomes.
TCROSS Co., Ltd. aims to transform pharmaceutical sales and marketing through a data-driven and scientific approach powered by AI and advanced analytics.
This approach is increasingly important not only in Japan but also in the United States, the world's largest pharmaceutical market. Following the presentation, conference participants visited the TCROSS booth and engaged in active discussions about the technology.
InsighTCROSS® is a decision-support model developed by TCROSS Co., Ltd. for pharmaceutical and medical device companies. By integrating statistical analysis and data science with traditional sales and marketing practices, InsighTCROSS® enables the visualisation of physicians’ prescribing behaviours and decision-making criteria. This approach supports more effective strategy development, allowing companies to optimise resource allocation and reduce marketing costs. Ultimately, InsighTCROSS contributes to more appropriate healthcare spending and the advancement of a sustainable healthcare system.